The Yale Child Study Center is an internationally recognized center of innovation in child and family mental health, dedicated to promoting healthy development and psychological well-being across the lifespan. We care for children and adolescents whose families are concerned about their child’s development and behavior. Common concerns include developmental delays, behaviors or worries that interfere with their child’s life, isolation and fear of school, and defiant and difficult behavior. Our first job is to listen. As we begin to understand the family and child, we will guide our patients through the evaluation, diagnosis, and treatment process. We provide office and home-based interventions as well as telehealth services, and we work with as many people involved in your child’s growth as possible, including parents, teachers and pediatricians. Above all, we care about your child’s development and your family’s well-being. We will use every means available—and maybe even invent some new ones—to help the child and their family. We are committed to working with every family to help them understand and address their child’s and family’s needs. Our interdisciplinary teams use up-to-date science to evaluate and then work with the family to develop a comprehensive treatment recommendations. Our treatment may include (one-on-one or group) therapy, family therapy, and parent-centered approaches and collaboration with schools. When appropriate, our providers will discuss the use of medication, providing detailed information so parents can make an informed decision. Many of our patients improve and thrive without medication, and for others it is a valuable part of their treatment. At the Yale Child Study Center, we are pioneering many treatments including approaches that help parents improve disruptive anger and aggression in children with autism and other developmental disorders. We are also developing new ways to help children overcome anxieties that may limit their daily lives, and treatment approaches designed to lessen the impact of an overwhelming event on the child and family. Finally, we work directly with parents around their own concerns about their roles as parents.

Our goal at the Diabetes Center is to give patients the tools necessary to successfully manage the day-to-day challenges of living with diabetes and prevent long-term diabetes complications. We provide comprehensive management and education for adults with type 1 and type 2 diabetes. We focus on lifestyle interventions and use the latest medications and technologies to improve our patients’ health. We also treat patients with: Pre-diabetes and metabolic syndrome Obesity Polycystic ovarian syndrome Lipid or cholesterol abnormalities Our nationally recognized doctors and nurse practitioners work as a team to address our patients’ needs in managing diabetes and other conditions. We understand that living with diabetes presents challenges. We focus on education and making patients their own advocates. Through the most current and state-of-the-art treatments, we will help them better manage their care. Oral Medications There are several classes of oral diabetes medications that we may prescribe if patients have type 2 diabetes. These medications differ in the way they work to reduce blood glucose levels. Frequently, oral medications from different classes are used in combination. Sulfonylureas: These drugs increase the amount of insulin produced by the pancreas. Meglitinides: These drugs rapidly increase the amount of insulin produced by the pancreas. Biguanides: Metformin is the only biguanide on the market. It is thought to work by reducing the production of glucose in the liver. Alpha-Glucosidase Inhibitors: These medications reduce the amount of glucose absorbed in the intestines. Thiazolidinediones: This agent makes the body more sensitive to insulin. Dipeptidyl Peptidase 4 inhibitors (DPP-4 inhibitors): These drugs increase the amount of insulin produced by the pancreas after a meal and reduce the amount of glucose produced by the liver. Injection Therapies There are several classes of injection therapies for diabetes. These treatments are given by an injection under the skin. The most common injection therapy is insulin, which comes in many different formulations that differ in how fast they work and how long they last. Below is a list of the different types of insulins. Technologies and Experimental Treatments Insulin Pumps: Insulin pumps were first pioneered at Yale in the 1970s. An insulin pump is an electronic, pager-sized, battery-powered device that delivers insulin continuously through a small plastic catheter under the skin. Insulin is delivered in different amounts (“basal” or “bolus” levels) during the day and controlled by the patient. While fasting, patients will administer a low level of continuous “basal” insulin to keep their blood glucose in the normal range. Prior to meals, they will determine a “bolus” of insulin based on the amount of carbohydrates in the meal. Continuous Glucose Monitoring systems (CGM): A CGM is a device that measures glucose under the skin (also known as “interstitial” glucose) every five minutes thr

Yale Psychiatry is the largest provider of psychiatric services in Connecticut, and the top National Institutes of Health-supported Department of Psychiatry in the United States. We are dedicated to adding to the body of knowledge in the field, and improving treatments for psychiatric disorders that span all ages. This includes helping people cope with major life events or medical illnesses, behavioral problems associated with personality disorder or addiction, mood and psychotic disorders, and dementia. Yale investigators have pioneered new treatments for nearly every psychiatric disorder. Our research programs have produced breakthroughs in areas as diverse as molecular neuroscience, genetics, translational neuroscience, neuroimaging, psychopharmacology, psychotherapy, rehabilitation, health services, forensic psychiatry, epidemiology, and health policy. Today, our clinicians are at the forefront of social, pharmacological, psychological, rehabilitative, and neurostimulation treatments. Through clinical trials, our interventional psychiatry service delivers high-impact treatments, including ECT (electroconvulsive therapy) and ketamine, for patients with treatment-resistant symptoms of depression. Our clinical programs are interwoven with our research efforts. We host programs that specialize in the major mental diseases and substance abuse treatment at three major institutions: Connecticut Mental Health Center, the Veterans Affairs Connecticut Healthcare System, and the Yale New Haven Psychiatric Hospital. We also provide increased psychiatry support for Smilow Cancer Hospital in areas such as smoking cessation.